Company / Working Capital per Share
Bio-Techne Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.73
FY2025
5-year range
$2.73 / $11.03
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
#107 of 158
Health Care
What the data says
At $2.73, Bio-Techne's working capital per share ranks #107 of 158 in the Health Care sector. Working Capital per Share has declined for 3 consecutive years, from $11.03 in FY2022 to $2.73 in FY2025.
Based on SEC 10-K filings.
2.73 in FY2025 with a 5-year CAGR of -24.2%.
Declined from $3.15 to $2.73 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -37.2%
- 5-Year CAGR
- -24.2%
- 10-Year CAGR
- -
Sector benchmark
#107 of 158 in Health CareTop 68% of 158This company $2.73 Sector average $24.43
▼
-88.8% below sector average
Key checks
Key Insights
- Bio-Techne's working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 5.9% year-over-year.
- Ranks #107 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.73 | -5.9% |
| FY2024 | $2.91 | -7.7% |
| FY2023 | $3.15 | -71.5% |
| FY2022 | $11.03 | +18.3% |
| FY2021 | $9.32 | -14.7% |
| FY2020 | $10.92 | +32.2% |
| FY2019 | $8.26 | -1.4% |
| FY2018 | $8.38 | +46.9% |
| FY2017 | $5.70 | +6.1% |
| FY2016 | $5.38 | -4.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026